Inflammation, atrophy, and prostate carcinogenesis
- PMID: 17826659
- DOI: 10.1016/j.urolonc.2007.05.007
Inflammation, atrophy, and prostate carcinogenesis
Abstract
The etiological agents that cause prostate cancer remain unknown. There is emerging evidence that "risk factor" lesions that are proposed to represent regenerative epithelium in response to environmental insults may precede the development of prostatic intraepithelial neoplasia and early carcinoma. Recent evidence suggests that these lesions, referred to collectively as proliferative inflammatory atrophy, may arise in the setting of inflammation and dietary toxins, such as "charred meat" carcinogens. Additional epidemiological, molecular pathological, and animal model work needs to be done to determine whether inflammation and atrophy are "driving" prostate carcinogenesis.
Similar articles
-
Prostate carcinogenesis and inflammation: emerging insights.Carcinogenesis. 2005 Jul;26(7):1170-81. doi: 10.1093/carcin/bgh317. Epub 2004 Oct 21. Carcinogenesis. 2005. PMID: 15498784 Review.
-
The role of inflammation and infection in the pathogenesis of prostate carcinoma.BJU Int. 2007 Oct;100(4):733-7. doi: 10.1111/j.1464-410X.2007.07091.x. Epub 2007 Jul 23. BJU Int. 2007. PMID: 17662075 Review.
-
Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate.Prostate. 2009 Sep 15;69(13):1378-86. doi: 10.1002/pros.20992. Prostate. 2009. PMID: 19507201
-
Inflammation and prostate cancer.Can J Urol. 2006 Feb;13 Suppl 1:46-7. Can J Urol. 2006. PMID: 16526982
-
Histopathological evidence for an association of inflammation with ductal pin-like lesions but not with ductal adenocarcinoma in the prostate of the noble rat.Prostate. 2008 May 15;68(7):728-39. doi: 10.1002/pros.20719. Prostate. 2008. PMID: 18302197
Cited by
-
Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-inflammatory cytokines/chemokines.EMBO Mol Med. 2012 Aug;4(8):791-807. doi: 10.1002/emmm.201101140. Epub 2012 Jun 29. EMBO Mol Med. 2012. PMID: 22745041 Free PMC article.
-
Genetic Polymorphisms in IL-10 Promoter Are Associated With Smoking and Prostate Cancer Risk in African Americans.Anticancer Res. 2020 Jan;40(1):27-34. doi: 10.21873/anticanres.13923. Anticancer Res. 2020. PMID: 31892550 Free PMC article.
-
ERG oncogene modulates prostaglandin signaling in prostate cancer cells.Cancer Biol Ther. 2011 Feb 15;11(4):410-7. doi: 10.4161/cbt.11.4.14180. Epub 2011 Feb 15. Cancer Biol Ther. 2011. PMID: 21178489 Free PMC article.
-
Metabolic imbalance and prostate cancer progression.Int J Mol Epidemiol Genet. 2010 Jul 25;1(4):248-71. Int J Mol Epidemiol Genet. 2010. PMID: 21532839 Free PMC article.
-
Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals.Mol Cancer. 2015 Jan 27;14(1):16. doi: 10.1186/s12943-014-0281-1. Mol Cancer. 2015. PMID: 25623427 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical